Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 391

1.

Impact of commonly used drugs on the composition and metabolic function of the gut microbiota.

Vich Vila A, Collij V, Sanna S, Sinha T, Imhann F, Bourgonje AR, Mujagic Z, Jonkers DMAE, Masclee AAM, Fu J, Kurilshikov A, Wijmenga C, Zhernakova A, Weersma RK.

Nat Commun. 2020 Jan 17;11(1):362. doi: 10.1038/s41467-019-14177-z.

2.

Intestinal barrier function is maintained with aging - a comprehensive study in healthy subjects and irritable bowel syndrome patients.

Wilms E, Troost FJ, Elizalde M, Winkens B, de Vos P, Mujagic Z, Jonkers DMAE, Masclee AAM.

Sci Rep. 2020 Jan 16;10(1):475. doi: 10.1038/s41598-019-57106-2.

3.

Optical diagnosis of T1 CRCs and treatment consequences in the Dutch CRC screening programme.

Meulen LWT, van de Wetering AJP, Debeuf MPH, Mujagic Z, Masclee AAM.

Gut. 2020 Jan 14. pii: gutjnl-2019-320403. doi: 10.1136/gutjnl-2019-320403. [Epub ahead of print] No abstract available.

PMID:
31937551
4.

Distal colonic transit is linked to gut microbiota diversity and microbial fermentation in humans with slow colonic transit.

Müller M, Hermes GDA, Canfora EE, Smidt H, Masclee AAM, Zoetendal EG, Blaak EE.

Am J Physiol Gastrointest Liver Physiol. 2019 Dec 23. doi: 10.1152/ajpgi.00283.2019. [Epub ahead of print]

PMID:
31869241
5.

Quality of life in irritable bowel syndrome: Authors' reply.

Mujagic Z, Weerts ZZRM, Vork L, Leue C, Kruimel JW, Hesselink M, Muris JWM, Jonkers DMAE, Masclee AAM, Keszthelyi D.

Neurogastroenterol Motil. 2020 Jan;32(1):e13729. doi: 10.1111/nmo.13729. No abstract available.

PMID:
31854094
6.

Percutaneous endoscopic versus radiologic gastrostomy for enteral feeding: a retrospective analysis on outcomes and complications.

Strijbos D, Keszthelyi D, Gilissen LPL, Lacko M, Hoeijmakers JGJ, van der Leij C, de Ridder RJJ, de Haan MW, Masclee AAM.

Endosc Int Open. 2019 Nov;7(11):E1487-E1495. doi: 10.1055/a-0953-1524. Epub 2019 Oct 23.

7.

Sugar Beet Pectin Supplementation Did Not Alter Profiles of Fecal Microbiota and Exhaled Breath in Healthy Young Adults and Healthy Elderly.

An R, Wilms E, Smolinska A, Hermes GDA, Masclee AAM, de Vos P, Schols HA, van Schooten FJ, Smidt H, Jonkers DMAE, Zoetendal EG, Troost FJ.

Nutrients. 2019 Sep 12;11(9). pii: E2193. doi: 10.3390/nu11092193.

8.

Ambient air quality as risk factor for microscopic colitis - A geographic information system (GIS) study.

Verhaegh BPM, Bijnens EM, van den Heuvel TRA, Goudkade D, Zeegers MP, Nawrot TS, Masclee AAM, Jonkers DMAE, Pierik MJ.

Environ Res. 2019 Nov;178:108710. doi: 10.1016/j.envres.2019.108710. Epub 2019 Aug 28.

PMID:
31520828
9.

Normal colonic transit time predicts the outcome of colonic manometry in patients with chronic constipation-an exploratory study.

Vork L, van Avesaat MHP, van Hoboken EA, Kruimel JW, Conchillo JM, Keszthelyi D, Masclee AAM.

Int J Colorectal Dis. 2019 Oct;34(10):1819-1822. doi: 10.1007/s00384-019-03376-1. Epub 2019 Aug 31.

PMID:
31471700
10.

Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome.

Weerts ZZRM, Masclee AAM, Witteman BJM, Clemens CHM, Winkens B, Brouwers JRBJ, Frijlink HW, Muris JWM, De Wit NJ, Essers BAB, Tack J, Snijkers JTW, Bours AMH, de Ruiter-van der Ploeg AS, Jonkers DMAE, Keszthelyi D.

Gastroenterology. 2020 Jan;158(1):123-136. doi: 10.1053/j.gastro.2019.08.026. Epub 2019 Aug 27.

PMID:
31470006
11.

The Impact of Pectin Supplementation on Intestinal Barrier Function in Healthy Young Adults and Healthy Elderly.

Wilms E, Jonkers DMAE, Savelkoul HFJ, Elizalde M, Tischmann L, de Vos P, Masclee AAM, Troost FJ.

Nutrients. 2019 Jul 9;11(7). pii: E1554. doi: 10.3390/nu11071554.

12.

Risk of impaired nutritional status and flare occurrence in IBD outpatients.

Spooren CEGM, Wintjens DSJ, de Jong MJ, van der Meulen-de Jong AE, Romberg-Camps MJ, Becx MC, Maljaars JP, van Bodegraven AA, Mahmmod N, Markus T, Hameeteman WM, Masclee AAM, Winkens B, Jonkers DMAE, Pierik MJ.

Dig Liver Dis. 2019 Sep;51(9):1265-1269. doi: 10.1016/j.dld.2019.05.024. Epub 2019 Jun 15.

PMID:
31213405
13.

Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome.

Weerts ZZRM, Vork L, Mujagic Z, Keszthelyi D, Hesselink MAM, Kruimel J, Leue C, Muris JWM, Jonkers DMAE, Masclee AAM.

Neurogastroenterol Motil. 2019 Aug;31(8):e13629. doi: 10.1111/nmo.13629. Epub 2019 May 22.

14.

Anaplastic Large Cell T Cell Lymphoma in a Patient With Severe Therapy-refractory Crohn's Disease on Long-standing Immunosuppressive Medication During Ustekinumab Treatment: A Case Report and Review of the Literature.

Smeets FGM, Liedorp PR, van der Poel M, Miclea RL, Masclee AAM, Pierik M.

J Crohns Colitis. 2019 Oct 28;13(11):1470-1473. doi: 10.1093/ecco-jcc/jjz084.

PMID:
31116402
15.

Diabetes mellitus, genetic variants in the insulin-like growth factor pathway and colorectal cancer risk.

de Kort S, Simons CCJM, van den Brandt PA, Janssen-Heijnen MLG, Sanduleanu S, Masclee AAM, Weijenberg MP.

Int J Cancer. 2019 Oct 1;145(7):1774-1781. doi: 10.1002/ijc.32365. Epub 2019 May 6.

16.

Therapeutic strategies in gastroparesis: Results of stepwise approach with diet and prokinetics, Gastric Rest, and PEG-J: A retrospective analysis.

Strijbos D, Keszthelyi D, Smeets FGM, Kruimel J, Gilissen LPL, de Ridder R, Conchillo JM, Masclee AAM.

Neurogastroenterol Motil. 2019 Jun;31(6):e13588. doi: 10.1111/nmo.13588. Epub 2019 Apr 4.

17.

Encapsulation of lipids as emulsion-alginate beads reduces food intake: a randomized placebo-controlled cross-over human trial in overweight adults.

Corstens MN, Troost FJ, Alleleyn AME, Klaassen T, Berton-Carabin CC, Schroën K, Masclee AAM.

Nutr Res. 2019 Mar;63:86-94. doi: 10.1016/j.nutres.2018.12.004. Epub 2018 Dec 8.

PMID:
30824401
18.

Intraintestinal Delivery of Tastants Using a Naso-Duodenal-Ileal Catheter Does Not Influence Food Intake or Satiety.

Klaassen T, Alleleyn AME, van Avesaat M, Troost FJ, Keszthelyi D, Masclee AAM.

Nutrients. 2019 Feb 23;11(2). pii: E472. doi: 10.3390/nu11020472.

19.

Faecal Microbiota Dynamics and their Relation to Disease Course in Crohn's Disease.

Galazzo G, Tedjo DI, Wintjens DSJ, Savelkoul PHM, Masclee AAM, Bodelier AGL, Pierik MJ, Jonkers DMAE, Penders J.

J Crohns Colitis. 2019 Sep 27;13(10):1273-1282. doi: 10.1093/ecco-jcc/jjz049.

20.

Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases.

Sanna S, van Zuydam NR, Mahajan A, Kurilshikov A, Vich Vila A, Võsa U, Mujagic Z, Masclee AAM, Jonkers DMAE, Oosting M, Joosten LAB, Netea MG, Franke L, Zhernakova A, Fu J, Wijmenga C, McCarthy MI.

Nat Genet. 2019 Apr;51(4):600-605. doi: 10.1038/s41588-019-0350-x. Epub 2019 Feb 18.

21.

Modulation of Intestinal Epithelial Permeability by Plasma from Patients with Crohn's Disease in a Three-dimensional Cell Culture Model.

Xu P, Elamin E, Elizalde M, Bours PPHA, Pierik MJ, Masclee AAM, Jonkers DMAE.

Sci Rep. 2019 Feb 14;9(1):2030. doi: 10.1038/s41598-018-38322-8.

22.

Impact of early events and lifestyle on the gut microbiota and metabolic phenotypes in young school-age children.

Zhong H, Penders J, Shi Z, Ren H, Cai K, Fang C, Ding Q, Thijs C, Blaak EE, Stehouwer CDA, Xu X, Yang H, Wang J, Wang J, Jonkers DMAE, Masclee AAM, Brix S, Li J, Arts ICW, Kristiansen K.

Microbiome. 2019 Jan 4;7(1):2. doi: 10.1186/s40168-018-0608-z.

23.

Crashing NASH in Patients Listed for Bariatric Surgery.

De Munck TJI, Verhaegh PLM, Verbeek J, Verheij J, Greve JW, Jonkers DMAE, Masclee AAM, Koek GH.

Obes Surg. 2019 Mar;29(3):1012-1014. doi: 10.1007/s11695-018-03637-y. No abstract available.

PMID:
30604081
24.

Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome.

Vich Vila A, Imhann F, Collij V, Jankipersadsing SA, Gurry T, Mujagic Z, Kurilshikov A, Bonder MJ, Jiang X, Tigchelaar EF, Dekens J, Peters V, Voskuil MD, Visschedijk MC, van Dullemen HM, Keszthelyi D, Swertz MA, Franke L, Alberts R, Festen EAM, Dijkstra G, Masclee AAM, Hofker MH, Xavier RJ, Alm EJ, Fu J, Wijmenga C, Jonkers DMAE, Zhernakova A, Weersma RK.

Sci Transl Med. 2018 Dec 19;10(472). pii: eaap8914. doi: 10.1126/scitranslmed.aap8914.

PMID:
30567928
25.

Development and Validation of a Patient-reported Score to Screen for Mucosal Inflammation in Inflammatory Bowel Disease.

de Jong MJ, Roosen D, Degens JHRJ, van den Heuvel TRA, Romberg-Camps M, Hameeteman W, Bodelier AGL, Romanko I, Lukas M, Winkens B, Markus T, Masclee AAM, van Tubergen A, Jonkers DMAE, Pierik MJ.

J Crohns Colitis. 2019 Apr 26;13(5):555-563. doi: 10.1093/ecco-jcc/jjy196.

PMID:
30476099
26.

The Experience Sampling Method-Evaluation of treatment effect of escitalopram in IBS with comorbid panic disorder.

Vork L, Mujagic Z, Drukker M, Keszthelyi D, Conchillo JM, Hesselink MAM, van Os J, Masclee AAM, Leue C, Kruimel JW.

Neurogastroenterol Motil. 2019 Jan;31(1):e13515. doi: 10.1111/nmo.13515. Epub 2018 Nov 20.

PMID:
30460734
27.

The Effect of an Encapsulated Nutrient Mixture on Food Intake and Satiety: A Double-Blind Randomized Cross-Over Proof of Concept Study.

Alleleyn AME, van Avesaat M, Ripken D, Bleiel SB, Keszthelyi D, Wilms E, Troost FJ, Hendriks HFJ, Masclee AAM.

Nutrients. 2018 Nov 17;10(11). pii: E1787. doi: 10.3390/nu10111787.

28.

Development of a real-time patient-reported outcome measure for symptom assessment in patients with functional dyspepsia using the experience sampling method.

Smeets FGM, Keszthelyi D, Vork L, Tack J, Talley NJ, Simren M, Aziz Q, Ford AC, Conchillo JM, Kruimel JW, Van Os J, Masclee AAM.

Neurogastroenterol Motil. 2019 Feb;31(2):e13496. doi: 10.1111/nmo.13496. Epub 2018 Nov 4.

PMID:
30393939
29.

Novel Perceived Stress and Life Events Precede Flares of Inflammatory Bowel Disease: A Prospective 12-Month Follow-Up Study.

Wintjens DSJ, de Jong MJ, van der Meulen-de Jong AE, Romberg-Camps MJ, Becx MC, Maljaars JP, van Bodegraven AA, Mahmmod N, Markus T, Haans J, Masclee AAM, Winkens B, Jonkers DMAE, Pierik MJ.

J Crohns Colitis. 2019 Mar 30;13(4):410-416. doi: 10.1093/ecco-jcc/jjy177.

PMID:
30371776
30.

A Novel Ileocolonic Release Peppermint Oil Capsule for Treatment of Irritable Bowel Syndrome: A Phase I Study in Healthy Volunteers.

Weerts ZZRM, Keszthelyi D, Vork L, Aendekerk NCP, Frijlink HW, Brouwers JRBJ, Neef C, Jonkers DMAE, Masclee AAM.

Adv Ther. 2018 Nov;35(11):1965-1978. doi: 10.1007/s12325-018-0802-1. Epub 2018 Oct 4.

PMID:
30284674
31.

Age-dependent changes in GI physiology and microbiota: time to reconsider?

An R, Wilms E, Masclee AAM, Smidt H, Zoetendal EG, Jonkers D.

Gut. 2018 Dec;67(12):2213-2222. doi: 10.1136/gutjnl-2017-315542. Epub 2018 Sep 7. Review.

PMID:
30194220
32.

Improving nutritional status assessment in patients with chronic pancreatitis.

Hintaran AD, Chenault MN, Verhaegh BPM, Reijven PLM, Masclee AAM, Keulemans YCA.

Pancreatology. 2018 Oct;18(7):785-791. doi: 10.1016/j.pan.2017.08.010. Epub 2017 Aug 30.

PMID:
30064905
33.

Update on the role of chromoendoscopy in colonoscopic surveillance of patients with Lynch syndrome.

van de Wetering AJP, Bogie RMM, Cabbolet ACOG, Winkens B, Masclee AAM, Sanduleanu S.

Eur J Gastroenterol Hepatol. 2018 Oct;30(10):1116-1124. doi: 10.1097/MEG.0000000000001214.

PMID:
30044237
34.

A Systematic Review and Meta-Analysis on Outcomes and Complications of Percutaneous Endoscopic Versus Radiologic Gastrostomy for Enteral Feeding.

Strijbos D, Keszthelyi D, Bogie RMM, Gilissen LPL, Lacko M, Hoeijmakers JGJ, van der Leij C, de Ridder R, de Haan MW, Masclee AAM.

J Clin Gastroenterol. 2018 Oct;52(9):753-764. doi: 10.1097/MCG.0000000000001082.

PMID:
29924079
35.

Volatile metabolites in breath strongly correlate with gut microbiome in CD patients.

Smolinska A, Tedjo DI, Blanchet L, Bodelier A, Pierik MJ, Masclee AAM, Dallinga J, Savelkoul PHM, Jonkers DMAE, Penders J, van Schooten FJ.

Anal Chim Acta. 2018 Sep 26;1025:1-11. doi: 10.1016/j.aca.2018.03.046. Epub 2018 Mar 30.

36.

Gastrointestinal cancer incidence in type 2 diabetes mellitus; results from a large population-based cohort study in the UK.

de Jong RGPJ, Peeters PJHL, Burden AM, de Bruin ML, Haak HR, Masclee AAM, de Vries F, Janssen-Heijnen MLG.

Cancer Epidemiol. 2018 Jun;54:104-111. doi: 10.1016/j.canep.2018.04.008. Epub 2018 May 16.

PMID:
29705628
37.

Incidence and Classification of Postcolonoscopy Colorectal Cancers in Inflammatory Bowel Disease: A Dutch Population-Based Cohort Study.

Wintjens DSJ, Bogie RMM, van den Heuvel TRA, le Clercq CMC, Oostenbrug LE, Romberg-Camps MJL, Straathof JW, Stassen LPS, Masclee AAM, Jonkers DMAE, Sanduleanu-Dascalescu S, Pierik MJ.

J Crohns Colitis. 2018 Jun 28;12(7):777-783. doi: 10.1093/ecco-jcc/jjy044.

PMID:
29648663
38.

Systematic review: Disease-specific instruments to assess gastrointestinal symptoms in functional dyspepsia.

Smeets FGM, Masclee AAM, Conchillo JM, Keszthelyi D.

Neurogastroenterol Motil. 2018 Mar 9. doi: 10.1111/nmo.13327. [Epub ahead of print]

PMID:
29520918
39.

Sacral neuromodulation versus personalized conservative treatment in patients with idiopathic slow-transit constipation: study protocol of the No.2-trial, a multicenter open-label randomized controlled trial and cost-effectiveness analysis.

Heemskerk SCM, Rotteveel AH, Benninga MA, Baeten CIM, Masclee AAM, Melenhorst J, van Kuijk SMJ, Dirksen CD, Breukink SO.

Int J Colorectal Dis. 2018 Apr;33(4):493-501. doi: 10.1007/s00384-018-2978-x. Epub 2018 Feb 22.

40.

Corticosteroid Sparing in Inflammatory Bowel Disease is More Often Achieved in the Immunomodulator and Biological Era-Results from the Dutch Population-Based IBDSL Cohort.

Jeuring SFG, Biemans VBC, van den Heuvel TRA, Zeegers MP, Hameeteman WH, Romberg-Camps MJL, Oostenbrug LE, Masclee AAM, Jonkers DMAE, Pierik MJ.

Am J Gastroenterol. 2018 Mar;113(3):384-395. doi: 10.1038/ajg.2017.482. Epub 2018 Jan 9.

PMID:
29317770
41.

Percutaneous endoscopic colostomy for adults with chronic constipation: Retrospective case series of 12 patients.

Strijbos D, Keszthelyi D, Masclee AAM, Gilissen LPL.

Neurogastroenterol Motil. 2018 May;30(5):e13270. doi: 10.1111/nmo.13270. Epub 2017 Dec 18.

PMID:
29250849
42.

Correction: Endoscopic subtypes of colorectal laterally spreading tumors (LSTs) and the risk of submucosal invasion: a meta-analysis.

Bogie RMM, Veldman MHJ, Snijders LARS, Winkens B, Kaltenbach T, Masclee AAM, Matsuda T, Rondagh EJA, Soetikno R, Tanaka S, Chiu HM, Sanduleanu-Dascalescu S.

Endoscopy. 2018 Mar;50(3):C4. doi: 10.1055/s-0043-124018. Epub 2017 Dec 14. No abstract available.

PMID:
29241275
43.

Letter: the neglected analgesic properties of red pepper in the clinical management of the irritable bowel syndrome pain-Authors' reply.

Beckers AB, Weerts ZZRM, Masclee AAM, Keszthelyi D.

Aliment Pharmacol Ther. 2018 Jan;47(1):154-155. doi: 10.1111/apt.14442. No abstract available.

44.

Endoscopic subtypes of colorectal laterally spreading tumors (LSTs) and the risk of submucosal invasion: a meta-analysis.

Bogie RMM, Veldman MHJ, Snijders LARS, Winkens B, Kaltenbach T, Masclee AAM, Matsuda T, Rondagh EJA, Soetikno R, Tanaka S, Chiu HM, Sanduleanu-Dascalescu S.

Endoscopy. 2018 Mar;50(3):263-282. doi: 10.1055/s-0043-121144. Epub 2017 Nov 27. Erratum in: Endoscopy. 2018 Mar;50(3):C4.

PMID:
29179230
45.

Development, content validity, and cross-cultural adaptation of a patient-reported outcome measure for real-time symptom assessment in irritable bowel syndrome.

Vork L, Keszthelyi D, Mujagic Z, Kruimel JW, Leue C, Pontén I, Törnblom H, Simrén M, Albu-Soda A, Aziz Q, Corsetti M, Holvoet L, Tack J, Rao SS, van Os J, Quetglas EG, Drossman DA, Masclee AAM.

Neurogastroenterol Motil. 2018 Mar;30(3). doi: 10.1111/nmo.13244. Epub 2017 Nov 6.

PMID:
29106029
46.

Patient-Reported Outcome Measures for Use in Clinical Trials and Clinical Practice in Inflammatory Bowel Diseases: A Systematic Review.

de Jong MJ, Huibregtse R, Masclee AAM, Jonkers DMAE, Pierik MJ.

Clin Gastroenterol Hepatol. 2018 May;16(5):648-663.e3. doi: 10.1016/j.cgh.2017.10.019. Epub 2017 Oct 23.

PMID:
29074448
47.

Postcolonoscopy mortality: Bowel preparation to blame?

Reumkens A, Masclee AAM, Bakker CM.

Gastrointest Endosc. 2017 Oct;86(4):744-745. doi: 10.1016/j.gie.2017.01.008. No abstract available.

PMID:
28917349
48.

Review article: transient receptor potential channels as possible therapeutic targets in irritable bowel syndrome.

Beckers AB, Weerts ZZRM, Helyes Z, Masclee AAM, Keszthelyi D.

Aliment Pharmacol Ther. 2017 Nov;46(10):938-952. doi: 10.1111/apt.14294. Epub 2017 Sep 8. Review.

49.

Lactobacillus plantarum Strains Can Enhance Human Mucosal and Systemic Immunity and Prevent Non-steroidal Anti-inflammatory Drug Induced Reduction in T Regulatory Cells.

de Vos P, Mujagic Z, de Haan BJ, Siezen RJ, Bron PA, Meijerink M, Wells JM, Masclee AAM, Boekschoten MV, Faas MM, Troost FJ.

Front Immunol. 2017 Aug 23;8:1000. doi: 10.3389/fimmu.2017.01000. eCollection 2017.

50.

Percutaneous endoscopic gastrostomy under conscious sedation in patients with amyotrophic lateral sclerosis is safe: an observational study.

Strijbos D, Hofstede J, Keszthelyi D, Masclee AAM, Gilissen LPL.

Eur J Gastroenterol Hepatol. 2017 Nov;29(11):1303-1308. doi: 10.1097/MEG.0000000000000959.

PMID:
28877087

Supplemental Content

Loading ...
Support Center